De novo transcriptome sequencing of Artemisia absinthium predicted anti-SARS-CoV2 (COVID-19) bioactive secondary metabolites

Key Points

• Bioactive secondary metabolites predicted to inhibit SARS-CoV2 have been identified.
• Key evidence includes specific metabolites associated with antiviral activity against COVID-19.
• Analysis focuses on de novo transcriptome sequencing of Artemisia absinthium to discover new compounds.
• These findings may highlight new avenues for COVID-19 treatment and herbal medicine applications.